Fluxergy, a medical diagnostics company, was founded with the mission to revolutionize point-of-care testing by bringing the variety of tests found in central labs to handheld devices. Their innovative platform integrates multi-modal detection technologies, enabling rapid and accurate molecular, immunochemistry, chemistry, PCR, and cytometry assays. Fluxergy aims to make laboratory-quality diagnostics accessible and affordable, catering to markets including clinical diagnostics, assay development, and equine health.
Notable figures associated with Fluxergy include leading experts in biomedical engineering and diagnostics. The company has attracted significant investment from prominent venture capital firms. Key achievements include the development of the first open platform for multimodal point-of-care assay development and testing, which has been recognized for its potential to transform healthcare delivery. Fluxergy's impact is evident in its ability to provide fast, reliable diagnostic results anywhere, significantly improving patient care and operational efficiency in various medical settings.